TheEdgeResearch
Home / Stocks / MTAC

MedTech Acquisition Corporation (MTAC)

NASDAQ Financial Services Shell Companies
$11.34 ▲ +18.67%
Market Cap
$83.9M
Sector
Financial Services
Industry
Shell Companies
Beta
-0.02
52-Wk Range
8.43-12.8299
CEO
Christopher C. Dewey
Country
US
Currency
USD

MedTech Acquisition Corporation operates in the Shell Companies industry of the Financial Services sector, headquartered in Greenwich, CT, US. The stock last traded at $11.34, up 18.67% on the session, giving a market capitalisation of $83.9M. On trailing twelve-month figures it carries a trailing P/E of -8.66, a net margin of -123.6%. Its beta of -0.02 implies it has historically moved less than the broad market.

Valuation & profitability (TTM)
P/E
-8.66
Price / Sales
1.86
Price / Book
95.11
EV / EBITDA
-6.93
Gross margin
85.8%
Operating margin
-67.7%
Net margin
-123.6%
Return on equity
—
Debt / equity
5.26
Current ratio
5.35
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
NASDAQ Capital Market
Employees
—
IPO date
2021-02-08
Headquarters
Greenwich, CT, US
About MedTech Acquisition Corporation

MedTech Acquisition Corporation currently has no significant active business operations. The firm's stated intention is to pursue and finalize a business combination — which could involve a merger, stock exchange, asset acquisition, or other forms of corporate restructuring — with one or more enterprises in the U.S. healthcare industry. Established in 2020, its corporate base is situated in Greenwich, Connecticut.

Comparable companies

MedTech Acquisition Corporation is most often compared with the following Financial Services names:

ARBGBLEUBLNGEACFAASMDAINRACPFTAQDROWRAC
More research on MTAC
MTAC technical analysis MTAC TheEdge Score Compare against peers
Open full interactive analysis & DCF →